In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
via Google News
The Latest on: Celiac disease
- $18 Billion Autoimmune Disease Diagnostic Market, 2025 - Rising Incidence of Autoimmune Diseases & High Occurrence of Rheumatoid Arthritison September 6, 2019 at 5:09 pm
Graves' disease, Hashimoto's thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia. Factors Driving the Autoimmune Disease Diagnostic Market Rising technological ...
- Allena Pharmaceuticals: Unique Treatment For Enteric Hyperoxaluria Not Reflected In Valuationon September 6, 2019 at 12:03 pm
EH can result from inflammatory bowel disease, short bowel syndrome, celiac disease or as a result of gastric bypass for obesity. Allena's stock has a market capitalization of $100 million (and $ ...
- Global Autoimmune Disease Diagnostic Market to 2025 by Disease, Tests Type, Regions - ResearchAndMarkets.comon September 6, 2019 at 8:11 am
Graves' disease, Hashimoto's thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia. Rising technological advancement in diagnostic, increasing patient awareness ...
- There's no point in going gluten-free unless you have celiac disease, study suggestson September 5, 2019 at 11:00 am
While one per cent of Canadians (350,000) have celiac disease — an immune response to eating gluten — and six per cent (2.1 million) gluten sensitivity, upwards of 20 per cent (more than 7 ...
- High Rates of Celiac Disease Among First-Degree Relativeson September 2, 2019 at 11:39 am
Celiac.com 09/02/2019 - A team of researchers recently set out to investigate rates of first-degree relatives (FDRs) with celiac disease detected at screening, and the diagnostic significance of ...
- 5 Alarming Symptoms Of Celiac Disease No Woman Should Ever Ignoreon September 2, 2019 at 10:38 am
Pizza, pasta, cake, bread, cookies, pastries, donuts, fried chicken — all of these foods have one thing in common (and it’s not just that they’re delicious): they have gluten in them. Today, one of ...
- Gluten intake during childhood may increase risk for celiac diseaseon August 29, 2019 at 4:02 am
High gluten intake during the first 5 years of life may increase the risk for celiac disease, according to findings published in JAMA. “Increased intake of gluten during the first 5 years of life is ...
- High Childhood Gluten Intake Increases Risk of Celiac Disease and Celiac Autoimmunityon August 28, 2019 at 7:07 pm
Celiac.com 08/26/2019 - Does the amount of gluten consumed during the first 5 years of life influence the risk of celiac disease autoimmunity and celiac disease in at-risk children? A new study says ...
- Eating gluten doesn’t cause symptoms in those without celiac disease or NCGS, study findson August 28, 2019 at 6:53 am
Gluten-free diets continue to be popular with millions of Americans, despite the fact that there’s no evidence that such a diet is any healthier for most people than one that contains gluten. The ...
via Bing News